TLX 2.74% $18.79 telix pharmaceuticals limited

Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS, page-14

  1. 6,091 Posts.
    lightbulb Created with Sketch. 556
    reading UBS they suggesting 25% market share ..... I wonder if this result is material enough for UBS to upgrade ?

    Best in class PFS and easier dosage gotta be good !
 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.